STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. GOVXW
  4. [EFFECT] GeoVax Labs, Inc. Warrants SEC Filing

[EFFECT] GeoVax Labs, Inc. Warrants SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 30, 2025 5:00 P.M.
Form: S-1
CIK: 0000832489
Company Name: GeoVax Labs, Inc.
File Number: 333-288085

Source: View Original Filing on SEC EDGAR

Stock GOVXW logo
Geovax Labs Inc

NASDAQ:GOVXW

GOVXW Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

GOVXW Latest News

Dec 9, 2024
GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
Nov 26, 2024
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
Nov 19, 2024
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
Nov 12, 2024
GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 5, 2024
GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GOVXW Latest SEC Filings

Sep 19, 2025
[424B5] GeoVax Labs, Inc. Prospectus Supplement (Debt Securities)
Aug 14, 2025
[SCHEDULE 13G/A] GeoVax Labs, Inc. Warrants SEC Filing
Aug 8, 2025
[Form 4] GeoVax Labs, Inc. Warrants Insider Trading Activity
Aug 1, 2025
[8-K] GeoVax Labs, Inc. Warrants Reports Material Event
Jul 28, 2025
[10-Q] GeoVax Labs, Inc. Warrants Quarterly Earnings Report

GOVXW Stock Data

2.35M
Biotechnology
Pharmaceutical Preparations
Link
United States
SMYRNA